CRISPR: Genome Editing and Cancer was ranked 7th on the List of Disruptive Dozen Technologies @2016 World Medical Innovation Forum
Reporter: Aviva Lev-Ari, PhD, RN
2.1.5.20 CRISPR: Genome Editing and Cancer was ranked 7th on the List of Disruptive Dozen Technologies @2016 World Medical Innovation Forum, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene Editing and DNA Repair
Disruptive Dozen Technologies: The Future of Cancer Therapies @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston
Other news on CRISPR from GenomeWeb
What’s Popular?
In Gene Silencing/Gene Editing
SOURCE
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aptubman
Arav Gandhi
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
FrasonKalapurackal
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22
Leave a Reply